AUS
NZ
UK
CA
USA
IND
In a strategic move to realign its focus and raise capital, Intel Corporation has sold its 1.18 million share stake in British chip firm Arm Holdings during the second quarter, according to a regulatory filing revealed on Tuesday. The sale, based on the average price of Arm's stock between April and June, likely generated approximately $146.7 million for the U.S.-based chipmaker. This divestment comes as Intel grapples with maintaining relevance in the highly competitive chip industry, where it has faced significant challenges.
Struggling to Compete, Intel Focuses on AI Chips and Manufacturing Expansion
Earlier this month, Intel announced plans to cut more than 15% of its workforce and suspend its dividend as it navigates a difficult period marked by reduced spending on traditional data center semiconductors. The industry is shifting towards artificial intelligence (AI) chips, an area where Intel has lagged behind rivals like Nvidia. In response, Intel has intensified its efforts to develop advanced AI chips and expand its manufacturing services, aiming to regain the technological edge lost to competitors such as Taiwan's TSMC, the world’s largest contract chipmaker.
This strategic pivot, led by CEO Pat Gelsinger, has increased operational costs and exerted pressure on profit margins, necessitating significant cost-cutting measures. The sale of Intel's stake in Arm Holdings is part of this broader initiative to streamline operations and focus on growth areas.
Intel's Stock Plummets Amid Workforce Reductions and Dividend Suspension
Intel's financial struggles have been reflected in its stock performance, with shares losing more than 59% of their value so far this year. The stock took a particularly sharp hit on August 2, plunging 26% following the announcement of the dividend suspension. Despite the recent sale of its stake in Arm Holdings, Intel's stock remained nearly flat in extended trading on Tuesday, indicating continued investor concern over the company’s long-term prospects.
As of the end of June, Intel reported cash and cash equivalents of $11.29 billion, alongside total current liabilities of approximately $32 billion. Both Intel and Arm declined to comment on the share sale when contacted by Reuters.
